Amyotrophic lateral sclerosis is not only a motor neuron disease: impact of the sympathoadrenal axis
نویسندگان
چکیده
Amyotrophic lateral sclerosis (ALS), an adult onset, fatal neurodegenerative disease, has as a cardinal pathogenic feature the selective death of motor neurons (MNs) at cortex, brainstem, and spinal cord. In this review we focus on four aspects: (i) hypothesis disease propagation through cerebrospinal fluid (CSF); (ii) distortion exocytotic release neurotransmitters sympathoadrenal axis; (iii) ultrastructural functional alterations mitochondria from adrenal medullary chromaffin cells (CCs); (iv) purinergic P2X7 receptor (P2X7R) potential target for neuroprotection. Concerning one to another area central nervous system (CNS), pattern clinical progression suggests that spreads centrifugally. This indicates kind toxin agent may be released propagated CSF. our laboratory found CSF ALS patients exerted toxic effects cultured cortical MNs. CCs, deep distortions kinetics fusion pore in process catecholamine release, SOD1G93A mouse model ALS. Furthermore, these could related accumulation mutated SOD1 into mitochondria; resulted mitochondrial depolarization, excess production reactive oxygen species deficiency oxidative phosphorylation. Finally, discuss recent data therapeutic effect compound JNJ-47965567, blocker P2X7Rs known central-stage neuroinflammation. Upon its chronic administration SOD1G93A, delayed onset but only females mice. conclusion, why MN selectively die remains mystery; On other hand, it seems cell types are also affected, particularly axis. As pathogenesis obscure, search targets slow ALS, puzzling.
منابع مشابه
Mantle cell lymphoma with amyotrophic lateral sclerosis (motor neuron disease)
We describe a previously unreported case of mantle cell lymphoma (MCL) associated to amyotrophic lateral sclerosis (ALS) in a 63-year-old woman with a 1-year history of weakness of arm and leg muscles. The both molecular-genetic and flow cytometry analysis of lymphocytes of peripheral blood (PB) demonstrated leukemic phase of MCL.
متن کاملRiluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
BACKGROUND Riluzole 100 mg probably prolongs survival in patients with amyotrophic lateral sclerosis by about two months and the safety of the drug is not a major concern. The evidence from randomized controlled trials indicates that patients taking riluzole probably survive longer than patients taking placebo. The beneficial effects are very modest and the drug is expensive. Adverse effects fr...
متن کاملMechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease.
BACKGROUND Amyotrophic lateral sclerosis, also known as motor neuron disease, is a fatal neurodegenerative disease. Neuromuscular respiratory failure is the commonest cause of death, usually within two to five years of the disease onset. Supporting respiratory function with mechanical ventilation may improve survival and quality of life. This is the first update of a review first published in 2...
متن کاملCell-based therapies for amyotrophic lateral sclerosis/motor neuron disease.
BACKGROUND Amyotrophic lateral sclerosis (ALS), which is also known as motor neuron disease (MND) is a fatal disease associated with rapidly progressive disability, for which no definitive treatment as yet exists. Current treatment regimens largely focus on relieving symptoms to improve the quality of life of those affected. Based on data from preclinical studies, cell-based therapy is a promis...
متن کاملMotor neuron disease (amyotrophic lateral sclerosis) arising from longstanding primary lateral sclerosis.
Three men were initially diagnosed as having primary lateral sclerosis (PLS), but eventually developed amyotrophic lateral sclerosis (ALS) after 7.5, 9, and at least 27 years. Non-familial ALS and PLS might be different manifestations of a single disease or constitute completely distinct entities. The clinical diagnosis of PLS predicts a median survival that is four to five times longer than in...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Anales de la Real Academia Nacional de Medicina
سال: 2022
ISSN: ['0034-0634', '2605-2512']
DOI: https://doi.org/10.32440/ar.2022.139.01.rev06